Evidence map›Paper›PMID 35502771›Full record

ArticleJournal of the American Heart Association2022

Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study.

Tomas Kovarnik, Matsuo Hitoshi, Ales Kral, Stepan Jerabek, David Zemanek, Yoshiaki Kawase, Hiroyuki Omori, Toru Tanigaki, Jan Pudil, Alexandra Vodzinska and 15 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Clinical Impact of Concordant and Discordant Physiology Parameters Post-Percutaneous Coronary Intervention in the EASY-PREDICT Study.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Trial
  4. Review
  5. Review
  6. Impact of Epicardial plaQUe Composition and geomeTry on Coronary hEmodynamics and Flow in Patients With Coronary Artery Disease (iEquate).Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Observational
  7. Review
  8. Coronary Artery Disease and Transcatheter Aortic Valve Replacement.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 8 institutions in 4 countries.

Tomas Kovarnik2nd Department of Medicine Department of Cardiovascular Medicine First Faculty of Medicine Charles University and General University Hospital in Prague Prague Czech Republic.ORCID 0000-0001-8308-4657
Matsuo HitoshiGifu Heart Center Gifu Japan.ORCID 0000-0002-1571-6533
Ales Kral2nd Department of Medicine Department of Cardiovascular Medicine First Faculty of Medicine Charles University and General University Hospital in Prague Prague Czech Republic.
Stepan Jerabek2nd Department of Medicine Department of Cardiovascular Medicine First Faculty of Medicine Charles University and General University Hospital in Prague Prague Czech Republic.
David Zemanek2nd Department of Medicine Department of Cardiovascular Medicine First Faculty of Medicine Charles University and General University Hospital in Prague Prague Czech Republic.
Yoshiaki KawaseGifu Heart Center Gifu Japan.
Hiroyuki OmoriGifu Heart Center Gifu Japan.
Toru TanigakiGifu Heart Center Gifu Japan.
Jan Pudil2nd Department of Medicine Department of Cardiovascular Medicine First Faculty of Medicine Charles University and General University Hospital in Prague Prague Czech Republic.
Alexandra VodzinskaCardiology Department of Trinec Podlesi Hospital Trinec Czech Republic.
Marian BrannyCardiovascular Department University Hospital Ostrava Ostrava Czech Republic.
Roman StipalDepartment of Internal Medicine and Cardiology University HospitalFaculty of MedicineMasaryk University Brno Brno Czech Republic.
Petr KalaDepartment of Internal Medicine and Cardiology University HospitalFaculty of MedicineMasaryk University Brno Brno Czech Republic.
Jan MrozekCardiovascular Department University Hospital Ostrava Ostrava Czech Republic.
Martin PorzerCardiovascular Department University Hospital Ostrava Ostrava Czech Republic.
Tomas GrezlCardiovascular Department University Hospital Ostrava Ostrava Czech Republic.
Kamil NovobilskyCardiology Department Municipal Hospital Ostrava Ostrava Czech Republic.
Oscar MendizFundacion Favaloro Buenos Aires Argentina.ORCID 0000-0002-5268-0429
Karel KoprivaCardiology Department Homolka Hospital Prague Czech Republic.
Martin MatesCardiology Department Homolka Hospital Prague Czech Republic.ORCID 0000-0002-3324-3469
Martin ChvalInstitute for Research and Development of Education Faculty of Education Charles University Prague Czech Republic.
Zhi ChenDepartment of Electrical & Computer Engineering Iowa Institute for Biomedical ImagingThe University of Iowa IA.
Pavel MartasekDepartment of Paediatrics and Inherited Metabolic Disorders First Faculty of Medicine Charles UniversityGeneral University Hospital Prague Czech Republic.
Ales Linhart2nd Department of Medicine Department of Cardiovascular Medicine First Faculty of Medicine Charles University and General University Hospital in Prague Prague Czech Republic.
FiGARO trial investigators
Charles University · CZUniversity Hospital Ostrava · CZGifu Heart Center · JPNa Homolce Hospital · CZMasaryk University · CZFavaloro Foundation · ARNemocnice Podlesí · CZUniversity of Iowa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The FiGARO (FFR versus iFR in Assessment of Hemodynamic Lesion Significance, and an Explanation of Their Discrepancies) trial is a prospective registry searching for predictors of fractional flow reserve/instantaneous wave-free ratio (FFR/iFR) discrepancy. Methods and Results FFR/iFR were analyzed using a Verrata wire, and coronary flow reserve was analyzed using a Combomap machine (both Philips-Volcano). The risk polymorphisms for endothelial nitric oxide synthase and for heme oxygenase-1 were analyzed. In total, 1884 FFR/iFR measurements from 1564 patients were included. The FFR/iFR discrepancy occurred in 393 measurements (20.9%): FFRp (positive)/iFRn (negative) type (264 lesions, 14.0%) and FFRn/iFRp (129 lesions, 6.8%) type. Coronary flow reserve was measured in 343 lesions, correlating better with iFR (R=0.56,

Indexed as

Coronary StenosisFractional Flow Reserve, MyocardialRenal InsufficiencyCoronary AngiographyFemaleHeme Oxygenase-1HemodynamicsHemoglobinsHumansMaleNitric Oxide Synthase Type IIIHeme Oxygenase-1HemoglobinsNitric Oxide Synthase Type IIIcoronary flow reservefractional flow reserveinstantaneous wave‐free ratio

Identifiers

PMID35502771
PMCPMC9238629
OpenAlexW4225394372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.